1/16
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Red blood cell physiology in Sickle-Cell Anaemia
Deformed, less flexible red blood cells
Acute complication of sickle-cell anaemia
Sickle-cell crisis: restricted blood supply to organs
Treatment for sickle-cell crisis
Hospitalisation → fluid replacement, analgesia, treat any infections
Long-term complications of sickle-cell anaemia
Anaemia. Leg ulcers. Renal failure. More susceptible to infections.
Treatment for haemolytic anaemia
Folic acid supplementation
Drug used to reduce frequency of painful sickle-cell crises and reduce transfusion requirements
Hydroxycarbamide
Full name of G6PD Deficiency
Glucose-6-phosphate dehydrogenase deficiency
Populations & gender where G6PD deficiency is more common
Common in Africa and Asia. More common in males.
People with G6PD deficiency are more susceptible to developing which type of anaemia?
Acute haemolytic anaemia
Drugs with definitive risk of haemolysis in most G6PD-deficient individuals
Dapsone and other sulfones. Fluoroquinolones. Nitrofurantoin. Quinolones. Sulfonamides. Primaquine
Drugs with possible risk of haemolysis in some G6PD-deficient individuals
Aspirin. Chloroquine. Menadione. Quinine. Sulfonylureas.
(Remember Quinine’s MACS)
Two causes of megaloblastic anaemia
Malabsorption of Vitamin B12. Folate deficiency.
Treatment for megaloblastic anaemia caused by Vitamin B12 deficiency
Hydroxocobalamin at intervals of up to 3 months. Frequent IM injections initially to replenish stores → maintenance
Left of daily folic acid supplementation in megaloblastic anaemia caused by folic acid deficiency
4 months
Treatment of megaloblastic anaemia in emergencies
Administer both (hydroxocobalamin and folic acid) while waiting for results
Drug to avoid giving alone if the cause of megaloblastic anaemia is undiagnosed and why
Don’t give folic acid alone if undiagnosed → can cause neuropathy
Risk factors for neural tube defects
Smoking. Sickle-cell anaemia. Diabetes. Obesity. Anti-epileptic drugs. Antimalarial drugs.